- $55.54m
- -$38.63m
- 24
- 44
- 11
- 16
Annual balance sheet for Rallybio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 19.5 | 140 | 175 | 169 | 110 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 20.9 | 141 | 181 | 179 | 115 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.199 | 0.287 | 0.511 | 0.909 | 0.592 |
| Long Term Investments | |||||
| Total Assets | 21.6 | 142 | 182 | 180 | 116 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Current Liabilities | 3.81 | 5.84 | 6.55 | 10.7 | 9.26 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 4.75 | 5.86 | 6.58 | 11.1 | 9.44 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 16.9 | 136 | 176 | 169 | 106 |
| Total Liabilities & Shareholders' Equity | 21.6 | 142 | 182 | 180 | 116 |
| Total Common Shares Outstanding |